BIO-Europe Spring® 2016: AngioDesign tailoring next-generation ACE inhibitors

May 17, 2016
Mario Ehlers, the chairman and founder of Angio-Design (UK) speaks to Informa senior editor and writer Sten Stovall during the BIO-Europe Spring® partnering conference in Stockholm, Sweden about the drug discovery group's use of structure-guided and computer-aided therapy design to proven disease targets and why the startup is focused on developing next-generation ACE inhibitors.
Previous Video
BIO-Europe Spring® 2016:  Accellta CEO says israeli stem cell specialist seeks global partners
BIO-Europe Spring® 2016: Accellta CEO says israeli stem cell specialist seeks global partners

Accellta CEO Itzchak Angel speaks to Informa senior editor and writer Sten Stovall during the BIO-Europe Sp...

Next Video
BIO-Europe Spring® 2016: 4SC AG's CSO outlines epigenetics strategy
BIO-Europe Spring® 2016: 4SC AG's CSO outlines epigenetics strategy

4SC AG Chief Science Officer Daniel Vitt speaks to Informa senior editor and writer Sten Stovall during the...